Bridging Implementation, Knowledge, and Ambition Gaps to Eliminate Tuberculosis in the United States and Globally

by Kenneth G. Castro, Philip A. LoBue
Published 2011-03-01

Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy

by Kevin L. Winthrop, Eric Chang, Shellie Yamashita, Michael F. Iademarco, Philip A. LoBue
Published 2009-10-01

Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis

by Colleen Scott, Joseph S. Cavanaugh, Benjamin J. Silk, Julia Ershova, Gerald H. Mazurek, Philip A. LoBue, Patrick K. Moonan
Published 2017-03-01

Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

by Roque Miramontes, Andrew N Hill, Rachel S Yelk Woodruff, Lauren A Lambert, Thomas R Navin, Kenneth G Castro, Philip A LoBue
Published 2015-01-01

Tuberculosis: a re-emerging disease in animals and humans

by Charles O. Thoen, DVM, PhD, Philip A. LoBue, MD, Donald A. Enarson, MD, John B. Kaneene, DVM, MPH, PhD, Isabel N. de Kantor, PhD
Published 2009-03-01

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens.

by Kathryn L Kellar, Jennifer Gehrke, Stephen E Weis, Aida Mahmutovic-Mayhew, Blachy Davila, Margan J Zajdowicz, Robin Scarborough, Philip A LoBue, Alfred A Lardizabal, Charles L Daley, Randall R Reves, John Bernardo, Brandon H Campbell, William C Whitworth, Gerald H Mazurek
Published 2011-01-01